A BioHealth research program selected by the French Ministry of Research and Education in the framework of the "Laboratoires d'Excellence" initiative.
EpiGenMed wants to foster the best BioHealth basic and clinical research and to encourage interdisciplinary projects. The EpiGenMed project was selected by the French Ministry of Research and Education in the framework of the national "Investments for the Future" program in 2011. The project received 12 million euros in funding for a 10-year period, essentially devoted to science training through the recruitment of PhD students, post-doctoral fellows and Chairs of Excellence.
EpiGenMed involves 58 of the best research groups in Montpellier, implicated in five areas of research that cover Genome and Epigenome Dynamics, Cell cycle, Cell fate and Development, Infectious diseases and Immunology, Cell signalling and Neurobiology, Biophysics and Systems biology. It is hosted by the University of Montpellier and national science institutions and benefits from an excellent industrial environment
Labex EpiGenMed 2018 PhD campaign
Admitted candidates in alphabetical order:
Ph.D. Program 2018
The International EpiGenMed PhD program of the University of Montpellier is currently accepting applications for 3-year Ph.D positions to be started on October 1, 2018.
The Labex (Laboratory of Excellence) EpiGenMed is a Health Sciences collaborative research program at the University of Montpellier that is financed by the Excellence Initiative of the French Ministry of Research and that involves the leading research laboratories of 14 scientific institutes in the area. Five major axes of research involving 58 top-level research groups are supported by this initiative:
• Genome and Epigenome
• Cell Cycle, Cell Fate and Development
• Infection and Immunity
• Integrating Systems in Neuroscience
• Biophysics and Systems Biology